October

October 4, 2014

Differentiation therapy for Human Leukaemia: BMP4 functions as an anti-cancer barrier by promoting differentiation of leukaemic cells via up regulation of Histone methyl-transferase MLL4, 04/October/2014, 12.00 pm

A recent study from the Laboratory of Genome Integrity, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA shows that “DNA-damage-induced differentiation of leukaemic cells as an […]
October 4, 2014

MiRNA-based Cancer therapy: MiRNA-373 increases the expression of tumor suppressor p53 via down regulation of its target gene, 04/October/2014, 08.31 am

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Citation: Boominathan, MiRNA-based Cancer therapy: MiRNA-373 increases the expression of  tumor suppressor p53 via down regulation of its target gene, 04/October/2014, 08.31 […]
October 4, 2014

MiRNA-based therapy for Psoriasis: MiRNA-144 inhibits psoriasiform skin inflammation via down regulation of its target gene, 04/October/2014, 08.13 am

A recent study from the Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts; Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA; and Institute for Biomedical Research, University College […]
October 4, 2014

MiRNA-based Cancer therapy: MiRNA-127 increases the expression of tumor suppressor p14/ARF via down regulation of its target gene, 04/October/2014, 07.58 am

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Citation: Boominathan, MiRNA-based Cancer therapy: MiRNA-127 increases the expression of  tumor suppressor p14/ARF via down regulation of its target gene, 04/October/2014, 07.58 […]